Related Experiment Videos
Does thyroid hormone have a role as adjunctive therapy in depression?
1Department of Medicine, Brown University School of Medicine, Rhode Island Hospital, Providence 02903, USA.
Thyroid : Official Journal of the American Thyroid Association
|February 1, 1996
Summary
Thyroid hormone therapy may help depression, especially when combined with antidepressants. Triiodothyronine (T3) may be effective for treatment-resistant depression in patients with subclinical hypothyroidism or autoimmune thyroiditis.
Area of Science:
- Endocrinology
- Psychiatry
- Pharmacology
Background:
- Depression is linked to thyroid axis dysfunction.
- Hypothyroidism can manifest as or exacerbate depression.
- The efficacy of thyroid hormone therapy in depression remains debated.
Purpose of the Study:
- To evaluate the role of thyroid hormone therapy in managing depression.
- To investigate the potential benefits of triiodothyronine (T3) as an adjuvant therapy for treatment-resistant depression.
Main Methods:
- Assessment of thyroid status in depressed patients.
- Consideration of L-thyroxine for overt hypothyroidism.
- Evaluation of T3 adjuvant therapy (25 mcg/day) for patients with subclinical hypothyroidism or autoimmune thyroiditis resistant to TCAs/SSRIs.
Main Results:
- Overt hypothyroidism causing depression should be treated with L-thyroxine.
- T3 adjuvant therapy shows promise for specific patient subgroups resistant to standard antidepressants.
- Evidence for T4 adjuvant therapy is less compelling than for T3.
- The role of T3 in patients without hypothyroidism and resistant to antidepressants is not established.
Conclusions:
- Careful thyroid evaluation is crucial for depressed patients.
- T3 adjuvant therapy warrants consideration in specific cases of treatment-resistant depression.
- Further multicenter controlled studies are needed to confirm the efficacy of T3 adjuvant therapy.